Evotec: Funding, Team & Investors | Startup Intros

Loading organizations...

Evotec: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Mar 14, 2024	Tubulis GmbH	$140.1M Series B	Christoph Broja, Kanishka Pothula	Sofia Ioannidou, Bayern Kapital, BioMedPartners, coparion, Deep Track Capital, Frazier Life Sciences, Caroline Goddeeris, High-Tech Grunderfonds, OCCIDENT, Seventure Partners
Nov 1, 2022	Carrick Therapeutics	$60.0M Series C	—	ARCH Venture Partners, Cambridge Innovation Capital, Google Ventures, Lightstone Ventures, Rosetta Capital
Nov 1, 2022	Cajal Neuroscience	$96.0M Series A	Lux Capital, The Column Group	Dimension Capital, LGF, Alexandria Venture Investments, Bristol Myers Squibb, Dolby Family Ventures, Two Sigma Ventures
May 1, 2022	Tubulis	$63.0M Series B	Andera Partners	5AM Ventures, Abingworth, Coparion, EQT Life Sciences, Frazier Healthcare Partners, Hakan Goker, Third Rock Ventures, Venrock, Versant Ventures, Bayern Kapital, Valentin Piech, Thomas Hanke, Jan Van den Bossche, High-Tech Grunderfonds, OCCIDENT, Seventure Partners
Feb 1, 2022	Centauri Therapeutics	$33.0M Series A	—	Boehringer Ingelheim Venture Fund, Animatrix Capital, Johannes Zanzinger, Karen Lackey, Kent Life Science, Camilla Petrycer Hansen, Wren Capital
Aug 1, 2021	Immunitas Therapeutics	$58.0M Series B	Agent Capital	Alta Partners, Cofounders Capital, Domain Associates, Leaps by Bayer, Longwood Fund, Novartis Venture Fund, Providence Ventures, RA Capital, Section 32, Netalie Nadivi, 120 Capital, Alexandria Venture Investments, Brian Halak, Mirae Asset, M Ventures, Novartis, NS Investment, Ono Venture Investment, Solasta Ventures, The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research
Jul 29, 2021	Topas Therapeutics	$21.3M Series B Extension	—	BioMedPartners, Boehringer Ingelheim, EMBL Ventures, Epidarex Capital, Werner Lanthaler, Gimv, Vesalius Biocapital
Mar 4, 2021	Exscientia	$100.0M Series C	—	William Abecassis, Bristol Myers Squibb, GT Healthcare Capital Partners, Novo Holdings
May 26, 2020	Exscientia	$60.0M Series C	Robert Ghenchev	Bristol Myers Squibb, GT Healthcare Capital Partners
Nov 1, 2019	Immunitas Therapeutics	$39.0M Series A	Juergen Eckhardt, Novartis	Novartis Venture Fund, Alexandria Venture Investments, M Ventures
Oct 1, 2019	Aeovian Pharmaceuticals	$37.0M Series A	Michael Powell	Apollo Health Ventures, Anthony Philippakis, venBio
Jan 7, 2019	Exscientia	$26.0M Series B	—	Celgene, GT Healthcare Capital Partners
Sep 28, 2017	Exscientia	$17.6M Other Equity	Werner Lanthaler	—
Apr 25, 2017	Forge Therapeutics	$15.0M Series A	Brian T. Dorsey	Jonathan Kabakoff, Mario Polywka, Jeffrey Moore, Red Apple Group, WS Investments
Oct 1, 2016	Carrick Therapeutics	$95.0M Series A	ARCH Venture Partners, Woodford Investment Management	Cambridge Enterprise, Robert Tansley, Werner Lanthaler, Google Ventures, Jason Lettmann
Mar 23, 2016	Topas Therapeutics	$15.6M Series A	Epidarex Capital	EMBL Ventures, Gimv